APA (7th ed.) Citation

Li, C., Sun, J., Xu, J., Wu, M., Li, X., Liu, Z., . . . Ding, Y. Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Cuiyun, Jixuan Sun, Jia Xu, Min Wu, Xiaojiao Li, Zhijie Liu, Qingfeng Dong, Yu Sun, and Yanhua Ding. Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Mepolizumab and BAT2606 in Healthy Chinese Men in a Double-blinded, Randomized, Single-dose, Three-arm Parallel-group Phase I Trial. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Cuiyun, et al. Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Mepolizumab and BAT2606 in Healthy Chinese Men in a Double-blinded, Randomized, Single-dose, Three-arm Parallel-group Phase I Trial. Frontiers Media S.A.